US 11376324
Sting activating nanovaccine for immunotherapy
granted A61KA61K2039/55555A61K2239/31
Quick answer
US patent 11376324 (Sting activating nanovaccine for immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/55555, A61K2239/31, A61K2239/38, A61K39/0011